Madden Securities Corp Gilead Sciences, Inc. Transaction History

Madden Securities Corp

$227 Million
Q3 2024

A detailed history of Madden Securities Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Madden Securities Corp holds 21,840 shares of GILD stock, worth $2.02 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

21,840

Previous 22,240 1.8%

Holding current value

$2.02 Million

Previous $1.53 Million 20.0%

% of portfolio

0.8%

Previous 0.68%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$66.59 - $83.99 $26,636 - $33,596	-400 Reduced 1.8%	21,840 $1.83 Million
Q2 2024 Jul 10, 2024	BUY	$63.15 - $72.88 $137,351 - $158,514	2,175 Added 10.84%	22,240 $1.53 Million
Q1 2024 Apr 09, 2024	BUY	$71.58 - $87.29 $1.44 Million - $1.75 Million	20,065 New	20,065 $1.47 Million
Q3 2023 Oct 10, 2023	BUY	$73.94 - $80.67 $295 - $322	4 Added 0.14%	2,782 $208,000
Q2 2023 Jul 06, 2023	SELL	$76.01 - $86.7 $14,973 - $17,079	-197 Reduced 6.62%	2,778 $214,000
Q1 2023 Apr 21, 2023	SELL	$77.31 - $88.08 $17,162 - $19,553	-222 Reduced 6.94%	2,975 $246,000
Q4 2022 Jan 10, 2023	SELL	$62.32 - $89.47 $7,540 - $10,825	-121 Reduced 3.65%	3,197 $0
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $17,623 - $20,130	-296 Reduced 8.19%	3,318 $205,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $230 - $260	4 Added 0.11%	3,614 $223,000
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $199,592 - $250,110	-3,446 Reduced 48.84%	3,610 $215,000
Q4 2021 Jan 14, 2022	SELL	$64.88 - $73.64 $59,819 - $67,896	-922 Reduced 11.56%	7,056 $512,000
Q3 2021 Oct 14, 2021	BUY	$67.69 - $73.03 $62,884 - $67,844	929 Added 13.18%	7,978 $557,000
Q2 2021 Jul 14, 2021	SELL	$63.47 - $69.35 $2,983 - $3,259	-47 Reduced 0.66%	7,049 $485,000
Q1 2021 Apr 30, 2021	SELL	$60.0 - $68.46 $71,760 - $81,878	-1,196 Reduced 14.42%	7,096 $459,000
Q4 2020 Jan 12, 2021	BUY	$56.65 - $64.55 $469,741 - $535,248	8,292 New	8,292 $483,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Madden Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Madden Securities Corp with notifications on news.

Account

Madden Securities Corp Gilead Sciences, Inc. Transaction History